KEY FINDINGS: An individualized, sequential treatment strategy may provide an effective approach to managing conjunctival melanocytic lesions across different histopathological grades. Topical chemotherapy may be particularly useful in diffuse lesions that cannot be completely removed surgically, while radiotherapy and additional chemotherapy may have a role in localized full-thickness HG-CMIL and invasive disease. Persistent pigmentation following initial treatment and nonbulbar tumor location warrant particular attention because of their association with local recurrence. In invasive conjunctival melanoma, ulceration, nonbulbar involvement, and greater tumor thickness may help identify patients at increased risk of metastatic spread. The findings should be interpreted in the context of the study's retrospective, single-center design, incomplete long-term follow-up in some patients, and limited metastatic events. Further multicenter research is needed to establish the comparative effectiveness of individual treatment modalities.
BACKGROUND: Conjunctival melanocytic lesions range from low-grade conjunctival melanocytic intraepithelial lesions (LG-CMIL) to high-grade lesions (HG-CMIL) and invasive conjunctival melanoma (iCoM). Their management can be challenging because of variations in disease extent, histopathological grade, and risk of local recurrence and metastasis. A sequential treatment strategy combining surgical biopsy, topical chemotherapy, and radiotherapy may help achieve disease control while tailoring treatment to individual lesion characteristics.
DETAILS: This single-center retrospective study, conducted at the Liverpool Ocular Oncology Centre, evaluated patients diagnosed with conjunctival melanocytic lesions between 2015 and 2025. The investigators assessed outcomes following an individualized, stepwise treatment approach based on histopathological findings and the clinical pattern of lesion growth. Treatment included excisional or incisional biopsy, topical chemotherapy, and adjuvant radiotherapy when indicated. The analysis included 165 eyes: 39 with LG-CMIL, 39 with HG-CMIL, and 87 with invasive conjunctival melanoma. Kaplan-Meier analysis and Cox proportional hazards regression were used to evaluate factors associated with local recurrence and metastatic disease. Particular attention was given to residual pigmentation following treatment, tumor location, ulceration, and tumor thickness. HG-CMIL lesions demonstrated the highest local recurrence rate (24.3%) and the shortest median time to recurrence (8.2 months). These lesions were frequently diffuse (71.1%), initially managed with incisional biopsy (59.0%), and associated with persistent residual pigmentation (55.6%). Local recurrence rates were 11.1% for LG-CMIL and 15.0% for invasive conjunctival melanoma. Across all lesion types, nonbulbar involvement (HR 2.76) and residual pigmentation after primary treatment (HR 2.77) were associated with increased local recurrence risk. Metastatic disease occurred exclusively in patients with invasive conjunctival melanoma, affecting 11.4% of this group. Independent risk factors associated with metastasis included ulcerative features (HR 15.08), nonbulbar involvement (HR 7.28), and increased tumor thickness (HR 2.15).
KEY FINDINGS: DSDO lenses were associated with modestly lower axial elongation than DIMS lenses in children with myopia, with greater differences in younger children and those with low myopia. In children without myopia, DSDO lens use was associated with less axial growth than no optical correction. Because lens selection reflected routine clinical decisions and parental preference rather than random allocation, residual confounding remains possible. The findings support further evaluation of individualized optical strategies for myopia control and prevention but do not establish that DSDO lenses are superior for every child.
BACKGROUND: Myopia in childhood is associated with progressive elongation of the eye, which can increase the risk of future ocular complications. Optical interventions designed to slow axial elongation are an important component of myopia management. Diversified segmental defocus optimization (DSDO) lenses are designed to influence peripheral retinal defocus, potentially limiting eye growth. However, evidence from routine clinical practice comparing these lenses with established defocus incorporated multiple segments (DIMS) lenses, particularly in children without myopia, remains important.
DETAILS: A prospective, multicenter clinical practice study conducted across eight Aier Eye Hospital Group centers in China evaluated 1,541 children and adolescents aged 6–16 years. The myopic cohort included 654 participants wearing DSDO lenses and 661 wearing DIMS lenses. The nonmyopic cohort included 85 participants wearing DSDO lenses and 141 untreated controls. Axial length was measured at baseline, six months, and 12 months. Propensity score matching was used to balance baseline characteristics, including age, sex, spherical equivalent, and axial length, between comparison groups.
Among children with myopia, mean axial elongation was lower with DSDO lenses than with DIMS lenses at six months (0.07 ± 0.12 mm versus 0.09 ± 0.10 mm; P = 0.026) and at 12 months (0.17 ± 0.18 mm versus 0.19 ± 0.16 mm; P = 0.019). Subgroup analyses indicated greater benefit among children aged 10 years or younger (P = 0.022) and those with low myopia (P = 0.001). Among nonmyopic participants, axial growth at 12 months was 0.18 ± 0.14 mm with DSDO lenses, compared with 0.29 ± 0.14 mm in untreated controls (P = 0.01). The difference was also significant among children with emmetropic or low hyperopic refractive error (P = 0.004). The greatest apparent effect in the nonmyopic cohort occurred during the first six months.
Copyright © Skyscape. All rights reserved.
Source: Wen, L., Yang, Y., He, Y., et al. Efficacy of Diversified Segmental Defocus Optimization Lenses on Axial Length Growth in Children and Adolescents with or without Myopia: Evidence from a Multicenter Clinical Practice. Ophthalmology. 2026; 133(10): 1197-1206. Published: October, 2026. DOI: 10.1016/j.ophtha.2026.04.015.
KEY FINDINGS: The development of NVG was associated with additional long-term systemic morbidity and mortality beyond the underlying PDR or CRVO in this large retrospective cohort. The strongest associations included mortality and ESRD among patients with PDR and mortality and stroke among those with CRVO. The findings suggest that development of NVG may identify patients with substantial systemic vascular risk and support closer coordination between ophthalmic and other medical specialties. Because the study was retrospective and based on electronic health records, the observed associations should not be interpreted as evidence that NVG itself directly causes these systemic outcomes.
BACKGROUND: Neovascular glaucoma (NVG) is a serious ocular complication of retinal vascular disease, including proliferative diabetic retinopathy (PDR) and central retinal vein occlusion (CRVO). Although NVG is primarily recognized for its effects on vision and intraocular pressure, less is known about whether its development is associated with additional long-term systemic health risks. This multicenter retrospective cohort study evaluated mortality and major systemic outcomes among adults with PDR or CRVO who did or did not subsequently develop NVG.
DETAILS: The investigators used the TriNetX Research Network, a deidentified electronic health record database containing information from more than 177 million patients across more than 150 healthcare organizations worldwide. Adults older than 40 years with PDR or CRVO were identified and compared according to whether NVG subsequently developed. Patients were propensity-score matched 1:1 based on demographic characteristics and comorbidities. Outcomes were assessed at 1, 5, and 10 years and included all-cause mortality, stroke, myocardial infarction (MI), end-stage renal disease (ESRD), and deep-vein thrombosis (DVT). A total of 1,278 patients with PDR and NVG were matched with 1,278 patients with PDR without NVG. The study also evaluated patients with CRVO and NVG compared with matched CRVO patients without NVG, as well as an NVG cohort compared with a cataract control cohort.
Among patients with PDR, development of NVG was associated with higher 10-year mortality (HR, 1.34; 95% CI, 1.14-1.57) and ESRD (HR, 1.43; 95% CI, 1.23-1.67) compared with PDR without NVG. Ten-year survival was 60.4% in the PDR + NVG group compared with 68.4% in the PDR without NVG group. Among patients with CRVO, those who developed NVG had higher 10-year mortality (HR, 1.61; 95% CI, 1.17-2.20) and stroke risk (HR, 1.86; 95% CI, 1.19-2.90). Differences in MI and ESRD were not statistically significant in this comparison, and DVT risk was also not significantly different. When PDR + NVG was compared directly with CRVO + NVG, the PDR + NVG group had higher 10-year risks of mortality (HR, 1.56; 95% CI, 1.17-2.07), MI (HR, 1.94; 95% CI, 1.13-3.32), and ESRD (HR, 4.04; 95% CI, 2.43-6.73). Compared with the cataract control cohort, NVG was associated at 10 years with higher risks of mortality (HR, 2.66; 95% CI, 2.40-2.94), stroke (HR, 2.17; 95% CI, 1.85-2.54), MI (HR, 1.89; 95% CI, 1.60-2.23), and ESRD (HR, 3.34; 95% CI, 2.89-3.88).
Copyright © Skyscape. All rights reserved.
Source: Margolis, R., Vasu, P., and Dorairaj, S. K. Long-Term Risk of Mortality and Systemic Morbidity in Neovascular Glaucoma: A Multicenter Retrospective Cohort Study. Ophthalmology Glaucoma. 2026; 9(5): 517-526. Published: September-October, 2026. DOI: 10.1016/j.ogla.2026.01.017.
KEY FINDINGS: In 203 nulliparous women assessed at 35+0 to 36+6 weeks, higher sFlt-1/PlGF ratios were associated with higher OA-PSV ratios, lower OA-PI, and higher MAP. An OA-PSV ratio 0.61 identified women with an sFlt-1/PlGF ratio <38 with 90.5% accuracy at a 15% false-positive rate. The findings suggest that OA Doppler, particularly the PSV ratio, may provide a noninvasive and accessible surrogate for angiogenic imbalance near term. Further validation is needed before OA Doppler can replace biochemical assessment in clinical practice.
BACKGROUND: Angiogenic imbalance, reflected by an elevated soluble fms-like tyrosine kinase-1 to placental growth factor (sFlt-1/PlGF) ratio, is associated with the pathophysiology of pre-eclampsia. Although the sFlt-1/PlGF ratio can help identify angiogenic imbalance, its use may be limited by cost and availability. This study evaluated whether ophthalmic artery (OA) Doppler parameters are associated with the sFlt-1/PlGF ratio and whether OA Doppler could help identify or exclude angiogenic imbalance in near-term pregnancy.
DETAILS: This cross-sectional cohort study was nested within the PE37 randomized controlled trial and included nulliparous women recruited between January 2023 and January 2025. Women underwent sFlt-1/PlGF measurement between 35+0 and 36+6 weeks' gestation. A subsample underwent OA Doppler assessment, including the OA peak systolic velocity (PSV) ratio and pulsatility index (PI), together with measurement of mean arterial pressure (MAP) and mean uterine artery PI. The Doppler operator was blinded to the sFlt-1/PlGF results. The analysis included 203 women, distributed across the lowest, middle, and highest sFlt-1/PlGF ratio tertiles as 62, 71, and 70 women, respectively.
Increasing sFlt-1/PlGF ratio was associated with progressive changes in OA Doppler measurements. The median OA-PSV ratio increased from 0.45 (IQR, 0.39–0.53) in the lowest tertile to 0.48 (IQR, 0.41–0.58) in the middle tertile and 0.59 (IQR, 0.50–0.66) in the highest tertile (adjusted P<0.001). Conversely, median OA-PI decreased from 2.20 (IQR, 1.92–2.61) to 2.13 (IQR, 1.86–2.37) and 1.86 (IQR, 1.60–2.26), respectively (adjusted P=0.031).
MAP also increased across the sFlt-1/PlGF tertiles, from 87.0 (IQR, 82.7–92.0) mmHg to 88.7 (IQR, 83.7–93.7) mmHg and 94.7 (IQR, 89.3–100.0) mmHg (adjusted P<0.001). In contrast, mean uterine artery PI did not demonstrate a significant trend across the sFlt-1/PlGF tertiles.
For identifying an sFlt-1/PlGF ratio <38, an OA-PSV ratio <0.61 correctly identified 90.5% of women at a 15% false-positive rate. The authors therefore identified OA Doppler, particularly the PSV ratio, as a potentially useful surrogate measure for angiogenic imbalance and a promising approach for ruling out abnormal angiogenic status.
Copyright © Skyscape. All rights reserved.
Source: Tinajero, M. F., Faraci, C., Cuenca, M., et al. Ophthalmic artery Doppler as potential surrogate marker of angiogenic imbalance in near-term pregnancy. Ultrasound in Obstetrics & Gynecology. 2026; 68(2):211–219. Published: August, 2026. DOI: 10.1002/uog.70270.
KEY FINDINGS: A two-round Delphi consensus involving medical retina specialists achieved agreement on 64/82 statements (78%) for managing CI-DMO. The framework supports personalised treatment, early assessment of anti-VEGF response at 3-6 months, and consideration of corticosteroid therapy after 9-12 months for persistent suboptimal response or high treatment burden. Prospective clinical validation is still required.
BACKGROUND: Management of centre-involving diabetic macular oedema (CI-DMO) can be challenging because treatment response varies and practical guidance on when to modify or switch therapy remains limited. Anti-vascular endothelial growth factor (VEGF) therapy is generally used first-line, while corticosteroids provide an alternative or second-line approach.
DETAILS: A two-round modified Delphi study was conducted among medical retina specialists in the National Health Service in England. A steering group developed 82 statements covering patient-centred care, baseline assessment and monitoring, definitions of treatment response, anti-VEGF switching criteria, corticosteroid use, and treatment stopping or switching criteria. Consensus was predefined as ≥75%.
Thirty specialists responded in round one and 39 in round two. Overall, consensus was achieved for 64/82 statements (78%). The panel strongly supported personalised treatment and comprehensive baseline assessment, including best-corrected visual acuity, intraocular pressure, and macular optical coherence tomography with central retinal thickness measurement.
The consensus defined non-response as a reduction in central retinal thickness (CRT) by ≤10% and suboptimal response as a 10-20% reduction. A positive response was defined as a ≥20% reduction in CRT with improvement or stabilisation of diabetic macular oedema-related best-corrected visual acuity.
The panel recommended evaluating anti-VEGF response at 3-6 months and after treatment with two different anti-VEGF agents. For patients with persistent suboptimal response or high treatment burden, there was moderate consensus supporting consideration of corticosteroid therapy after 9-12 months.
For patients demonstrating a positive response after 1-2 injections of a short-acting corticosteroid, 63% strongly agreed and 27% tended to agree that transition to a long-acting corticosteroid should be considered. The panel also supported assessing anti-VEGF treatment burden after 9-12 months and considering corticosteroid therapy when treatment burden is high.
The recommendations emphasize that treatment decisions should incorporate anatomical response, visual outcomes, patient factors, treatment preferences, and tolerance. However, the authors noted that the pathway is based on expert consensus rather than prospective clinical validation, and all panellists were from England.
Copyright © Skyscape. All rights reserved.
Source: Gale, R., Bailey, C., Devonport, H., et al. Modified Delphi Expert Consensus on the Optimal Intravitreal Treatment Pathway for Centre Involving Diabetic Macular Oedema Patients Within the National Health Service. BMJ Open Ophthalmology. 2026; 11: ve002787. Published: August 20, 2026. DOI: 10.1136/bmjophth-2026-002787.
KEY FINDINGS: In this large global series, ILM flap techniques demonstrated an important role in the management of large HMMHs and appeared more suitable than conventional ILM peeling as hole size increased. For very large defects, particularly those with a minimum diameter of >1000 µm, AMT or ART may offer an advantage because closure rates appeared less dependent on hole size. Meaningful visual improvement was observed across surgical approaches, supporting active surgical management in these complex cases. Interpretation should consider the retrospective design, variation in surgical practices among centers, and the small numbers of patients treated with AMT and ART.
BACKGROUND: Large high-myopic macular holes (HMMHs) are surgically challenging, and closure rates are lower than those reported in non-highly myopic eyes. The relative effectiveness of conventional internal limiting membrane (ILM) peeling, ILM flap techniques, and tissue-based approaches may vary according to macular hole size.
DETAILS: This global, multicenter, retrospective case series included 499 eyes of 463 patients with large HMMHs, defined by a minimum linear diameter of >=400 µm. Surgeries were performed between 2013 and 2023 by 37 surgeons worldwide, with a minimum follow-up of 3 months and a mean follow-up of 18.8 months. Surgical approaches included ILM peeling (n = 127), ILM flap (n = 285), amniotic membrane transplantation (AMT; n = 19), autologous retinal transplantation (ART; n = 36), and other techniques (n = 32). The primary outcome was macular hole closure at postoperative month 3, while secondary outcomes included changes in best-corrected visual acuity (BCVA). Outcomes were stratified according to the CLOSE Study Group size classification. The overall macular hole closure rate at 3 months was 72.4%. Closure rates decreased significantly as hole size increased following ILM peeling and ILM flap procedures. In contrast, closure rates with AMT and ART were not associated with increasing hole size, suggesting that tissue-based techniques may reduce the effect of defect size on surgical success in the largest HMMHs. Despite differences in anatomic closure across procedures, BCVA improved significantly from baseline at all follow-up time points in all surgical groups, with a mean final improvement of approximately 14.5 ETDRS letters.
Copyright © Skyscape. All rights reserved.
Source: Chau, V. Q., Abreu-Arbaje, N. A., Kitahata, S., et al. Surgical Management and Outcomes of Large High Myopic Macular Holes: Global Macular Hole Multicenter Study 3. Ophthalmology Retina. 2026; 46(8): 1345-1362 Published: August, 2026. DOI: 10.1097/IAE.0000000000004871
Specialty: